tradingkey.logo

Integra Lifesciences Holdings Corp

IART
10.930USD
-0.330-2.93%
收盘 02/09, 16:00美东报价延迟15分钟
586.85M总市值
亏损市盈率 TTM

Integra Lifesciences Holdings Corp

10.930
-0.330-2.93%

关于 Integra Lifesciences Holdings Corp 公司

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Integra Lifesciences Holdings Corp简介

公司代码IART
公司名称Integra Lifesciences Holdings Corp
上市日期Aug 16, 1995
CEOPoul (Mojdeh)
员工数量4396
证券类型Ordinary Share
年结日Aug 16
公司地址1100 Campus Road
城市PRINCETON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编08540
电话16092750500
网址https://www.integralife.com/
公司代码IART
上市日期Aug 16, 1995
CEOPoul (Mojdeh)

Integra Lifesciences Holdings Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
+26531.00%
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
89.14K
+19200.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
58.58K
-2561.00%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
35.79K
-4282.00%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
21.94K
+8684.00%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
Mr. Michael J. Mcbreen
Mr. Michael J. Mcbreen
Executive Vice President, President - Codman Specialty Surgical
Executive Vice President, President - Codman Specialty Surgical
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
+26531.00%
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
89.14K
+19200.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
58.58K
-2561.00%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
35.79K
-4282.00%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
21.94K
+8684.00%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Neurosurgery
201.56M
50.13%
Wound Reconstruction and Care
83.99M
20.89%
Instruments
50.15M
12.47%
ENT
40.87M
10.16%
Private Label
25.49M
6.34%
地区USD
名称
营收
占比
United States
295.85M
73.58%
Europe
42.89M
10.67%
Asia Pacific
42.68M
10.62%
Rest of World
20.64M
5.13%
业务
地区
业务USD
名称
营收
占比
Neurosurgery
201.56M
50.13%
Wound Reconstruction and Care
83.99M
20.89%
Instruments
50.15M
12.47%
ENT
40.87M
10.16%
Private Label
25.49M
6.34%

股东统计

更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
11.92%
TRU ST Partnership, L.P.
10.93%
Rubric Capital Management LP
9.83%
The Vanguard Group, Inc.
9.13%
Fuller & Thaler Asset Management Inc.
5.03%
其他
53.16%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
11.92%
TRU ST Partnership, L.P.
10.93%
Rubric Capital Management LP
9.83%
The Vanguard Group, Inc.
9.13%
Fuller & Thaler Asset Management Inc.
5.03%
其他
53.16%
股东类型
持股股东
占比
Investment Advisor
36.70%
Investment Advisor/Hedge Fund
36.64%
Hedge Fund
18.48%
Corporation
10.93%
Individual Investor
3.20%
Research Firm
2.31%
Pension Fund
1.48%
Bank and Trust
0.40%
Sovereign Wealth Fund
0.04%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
584
74.73M
95.94%
-24.99M
2025Q3
583
73.55M
94.42%
-25.07M
2025Q2
600
89.38M
114.72%
-18.72M
2025Q1
635
87.01M
111.97%
-18.30M
2024Q4
636
81.93M
106.10%
-20.27M
2024Q3
638
82.93M
106.93%
-12.58M
2024Q2
628
84.82M
107.92%
-1.75M
2024Q1
613
79.36M
101.18%
-3.69M
2023Q4
597
79.81M
101.26%
-5.74M
2023Q3
592
81.88M
100.31%
-3.94M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
9.29M
11.92%
-146.58K
-1.55%
Sep 30, 2025
TRU ST Partnership, L.P.
8.52M
10.93%
--
--
Feb 28, 2025
Rubric Capital Management LP
7.65M
9.83%
+300.00K
+4.08%
Sep 30, 2025
The Vanguard Group, Inc.
7.29M
9.36%
-217.24K
-2.89%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
3.91M
5.03%
+21.91K
+0.56%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.18M
4.09%
+267.13K
+9.16%
Sep 30, 2025
Invesco Advisers, Inc.
3.18M
4.09%
+3.31K
+0.10%
Sep 30, 2025
State Street Investment Management (US)
2.79M
3.58%
-35.57K
-1.26%
Sep 30, 2025
Boston Management and Research
2.74M
3.52%
--
--
Sep 30, 2025
Paradigm Capital Management, Inc.
2.53M
3.25%
+348.30K
+15.97%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Neuroscience and Healthcare ETF
1.44%
State Street SPDR S&P Health Care Equipment ETF
1.39%
ROBO Global Healthcare Technology & Innovation ETF
1.02%
Invesco S&P SmallCap Health Care ETF
0.49%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Inspire Small/Mid Cap ESG ETF
0.19%
Royce Quant Small-Cap Quality Value ETF
0.13%
Principal U.S. Small-Cap ETF
0.13%
iShares S&P Small-Cap 600 Value ETF
0.12%
State Street SPDR S&P 600 Small Cap Value ETF
0.11%
查看更多
iShares Neuroscience and Healthcare ETF
占比1.44%
State Street SPDR S&P Health Care Equipment ETF
占比1.39%
ROBO Global Healthcare Technology & Innovation ETF
占比1.02%
Invesco S&P SmallCap Health Care ETF
占比0.49%
Invesco NASDAQ Future Gen 200 ETF
占比0.43%
Inspire Small/Mid Cap ESG ETF
占比0.19%
Royce Quant Small-Cap Quality Value ETF
占比0.13%
Principal U.S. Small-Cap ETF
占比0.13%
iShares S&P Small-Cap 600 Value ETF
占比0.12%
State Street SPDR S&P 600 Small Cap Value ETF
占比0.11%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI